Not Yet Recruiting DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers NCT07707895 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology, +11 more Locations MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States University of Kentucky Medical Center — Lexington, Kentucky, United States Chris Obrien Lifehouse — Camperdown, New South Wales, Australia Universitair Ziekenhuis Antwerpen — Edegem, Belgium View all 27 locations View more locations Show fewer locations Loading locations... View Trial Details
